Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dual Trigger, Urinary HCG or Recombinant HCG, Which is the Best !? a Prospective Randomized Controlled Comparative Study

NCT04265495 is registered in ClinicalTrials.gov with Al Baraka Fertility Hospital as lead sponsor.

NCT NCT04265495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04265495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dual Trigger, Urinary HCG or Recombinant HCG, Which is the Best !? a Prospective Randomized Controlled Comparative Study
Lead sponsor
Al Baraka Fertility Hospital
Phase
Observational
Overall status
Unknown status
Start date
February 9, 2020
Completion date
December 1, 2021
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ivf